Updates on Regional Strategy to Address Opioid Crises

AGENDA
3:00 – 3:10

Overview of the KC Quality & Value Innovation Consortium (QVIC), and the Origins of a Regional Strategy to Address Opioid Crises

• John A. Spertus, MD, MPH, FACC, FAHA | Professor, UMKC Daniel J. Lauer / Missouri Endowed Chair in Metabolic & Vascular Disease Research Clinical Advisor; Director, UMKC Healthcare Institute for Innovations in Quality (HI-IQ) | KC Quality & Value Innovation Consortium (QVIC)
• Stacy L Farr, PhD, MPH | Research Assistant Professor, University of Missouri Kansas City (UMKC) and Co-Director, UMKC Healthcare Institute for Innovations in Quality (HI-IQ) | KC Quality & Value Innovation Consortium (KC QVIC)

3:10 – 3:25

Overview of the KC EPICC Project from a Pre-Implementation Perspective

• Holly Hagle, PhD, Associate Research Professor, University of Missouri-Kansas City
• Yifei Liu, PhD, Associate Professor, University of Missouri Kansas City School of Pharmacy

3:25 – 3:40

Implementation – EPICC: Hope Dealers

• Kristin Feeback, Psy.D, LSCSW President/CEO of CommCare and Alternatives EAP
• Jennifer Wolfe, CPS, Interim Director, CommCARE

3:40 – 3:55

Findings – Mixed Methods Evaluation of KC-EPICC

• Danielle Olds, Danielle Olds, MPH, PhD, RN Manager of Outcomes Research, Saint Luke’s Hospital, and Healthcare Institute for Innovations in Quality (HI-IQ), University of Missouri-Kansas City
• Tracey LaPierre, PhD, Associate Professor, Department of Sociology, University of Kansas

3:55 – 4:10

Community Perspective – The Burden of Opioid Use Disorder in Missouri During the COVID-19 Pandemic

• Shawn Billings, Vice President, Substance Use Programming, Missouri Hospital Association (MHA) 4:10 – 4:30

Questions & Discussion –

• Stacy L Farr, PhD, MPH | Research Assistant Professor, University of Missouri Kansas City (UMKC) and Co-Director, UMKC Healthcare Institute for Innovations in Quality (HI-IQ) | KC Quality & Value Innovation Consortium (KC QVIC)